Related Experiment Video
Updated: Jun 10, 2025

06:30
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
3.0K
Considerations for Using Phage Display Technology in Therapeutic Antibody Drug Discovery.
Mary Ann Pohl1, Juan C Almagro2
1Ailux Biologics, Somerville, Massachusetts 02143, USA maryann.pohl@xtalpi.com.
Cold Spring Harbor Protocols
|October 16, 2024
Summary
Phage display technology enables rapid identification and engineering of therapeutic antibody fragments. Strategic design of antibody discovery campaigns is crucial for developing effective biologic-based therapeutics.
Area of Science:
- Biotechnology
- Immunology
- Drug Discovery
Background:
- Phage display is a powerful platform for identifying and engineering biologic therapeutics.
- Antibody fragments can be rapidly discovered with high specificity and affinity using this technology.
Purpose of the Study:
- To outline key aspects of developing an antibody discovery strategy using phage display.
- To guide the identification of antibody fragments for therapeutic development.
Main Methods:
- Utilizing standard molecular biology techniques to create diverse antibody phage-displayed libraries.
- Employing phage panning campaigns to identify target-specific antibody fragments.
Main Results:
- Demonstrates the versatility of phage display for antibody discovery.
- Highlights the importance of strategic campaign design for successful therapeutic development.
Conclusions:
- Phage display is an effective method for discovering therapeutic antibody fragments.
- Careful planning and execution of discovery campaigns are essential for identifying desirable molecules for therapeutic applications.

